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(57) ABSTRACT
Carbon nanotubes (CNTs) are dispersed in an aqueous buffer
solution consisting of at least 50 weight percent water and a
remainder weight percent that includes a buffer material. The
buffer material has a molecular structure defined by a first
end, a second end, and a middle disposed between the first and
second ends. The first end is a cyclic ring with nitrogen and
oxygen heteroatomes, the middle is a hydrophobic alkyl
chain, and the second end is a charged group.
18 Claims, 1 Drawing Sheet
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AQUEOUS SOLUTION DISPERSEMENT OF
CARBON NANOTUBES
Pursuant to 35 U.S.C. §119, the benefit of priority from
provisional application 60/990,122, with a filing date of Nov. 5
26, 2007, is claimed for this non-provisional application.
ORIGIN OF THE INVENTION
The invention was made in part by employees of the United 
10States Government and may be manufactured and used by or
for the Government of the United States of America for gov-
ernmental purposes without the payment of any royalties
thereon or therefor.
BACKGROUND OF THE INVENTION	 15
1. Field of the Invention
This invention relates to methods of dispersing carbon
nanotubes in solutions. More specifically, the invention is a
method of aqueous solution dispersement of carbon nano- 20
tubes.
2. Description of the Related Art
Carbon nanotubes (CNTs) possess superior mechanical
and electrical properties thereby making them a potential
material of choice for a wide variety of applications. How-
ever, CNTs are not readily dispersed in a solvent because of 25
substantial van der Waals attraction between CNTs. Unfortu-
nately, dispersion of CNTs into individual tubes or small
bundles of tubes in often desirable when another material is to
be bonded to the CNTs. That is, if the CNTs can be dispersed
prior to having a material bonded thereto, the resulting mate- 30
rial tends to exhibit homogenous properties.
The choice of dispersing solvent must be compatible with
the CNTs, the material being bonded thereto, and possibly the
ultimate application environment. Ideally, the dispersing sol-
vent is a water-based or aqueous system owing to water's low 35
cost, ready availability, and non-toxic nature. Use of an aque-
ous dispersing solution is especially desirable in biomedical
or biophysical applications. However, the hydrophobic nature
of CNTs has made it difficult to disperse CNTs in an aqueous
system.
To combat the CNTs aversion to dispersion in an aqueous 40
system, surfactants or amphiphilic polymers are typically
added to the aqueous system. Exemplary surfactants or poly-
mers include sodium dodecyl sulfate (SDS), sodium dodecyl-
benzene sulfonate (NADDBS), TRITON X-100, TWEEN 20,
PLURONIC P103, dodecyltrimethylammonium bromide 45
(DTAB), DNA and polystyrene)-poly-(ethylene oxide) (Ps-
PEO) diblock copolymer. CNT dispersion is stabilized as the
surfactants wrap around the CNTs.
For dispersions requiring a high concentration of CNTs
(i.e., higher than 0.1 mg/ml), the surfactant concentration 50
required usually exceeds critical micelle concentrations to
prevent re-aggregation of the CNTs after dispersion. How-
ever, most surfactants are not biocompatible and are difficult
to remove from final products due to their strong adsorption
onto the CUT surfaces. Also, surfactants hinder binding of 55
reactants onto CNTs due to their tight wrapping of CNT
surfaces. A low-power and high frequency sonicator is often
utilized to make the suspension of CNTs with conventional
surfactants. However, this process takes a long time (e.g.,
normally sonication for over 24 hours is required using this
approach) to make a well-dispersed CNT suspension. 	 60
SUMMARY OF THE INVENTION
Accordingly, it is an object of the present invention to
provide a method of dispersing CNTs in a solution. 	 65
Another object of the present invention is to provide a
method of dispersing CNTs using an aqueous solution.
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Still another object of the present invention is to provide a
method of dispersing CNTs in an aqueous solution that sup-
ports subsequent binding of a reactant to the CNTs so-dis-
persed.
Other objects and advantages of the present invention will
become more obvious hereinafter in the specification and
drawings.
In accordance with the present invention, carbon nano-
tubes (CNTs) are dispersed in an aqueous buffer solution
consisting of at least 50 weight percent water and a remainder
weight percent that includes a buffer material. The buffer
material has a molecular structure defined by a first end, a
second end, and a middle disposed between the first and
second ends. The first end is a cyclic ring with nitrogen and
oxygen heteroatomes, the middle is a hydrophobic alkyl
chain, and the second end is a charged group. CNTs are mixed
in the aqueous buffer solution in a ratio of up to approximately
1.0 milligrams of CNTs per 1.0 milliliter of the aqueous
buffer solution wherein a resulting solution includes the
CNTs dispersed therein.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a molecular structure of 3-(N-morpholino)-pro-
panesulfonic acid (MOPS) buffer material used in an aqueous
buffer solution in accordance with the present invention;
FIG. 2 is a "scanning transmission electron microscopy"
(STEM) image of CNTs having a population of platinum-
core ferritins embedded therein resulting from mixing the
platinum-core ferritins in the aqueous buffer solution; and
FIG. 3 is a STEM image of CNTs having a population of
platinum-core cationized ferritins coupled thereto resulting
from mixing the platinum-core cationized ferritins in the
aqueous buffer solution.
DETAILED DESCRIPTION OF THE INVENTION
The present invention is a method of dispersing carbon
nanotubes (CNTs) in an aqueous solution without additives
such as surfactants, polymers, etc., that tend to wrap about the
dispersed CNTs. As used herein, the term CNTs includes
single-wall CNTs (SWCNTs), few-wall CNTs (FWCNTs),
multi-wall CNTs (MWCNTs), and mixtures thereof.
The present invention utilizes an aqueous buffer solution as
the vehicle for CNT dispersion. As is known in the art, a buffer
solution is an aqueous solution consisting of either a weak
acid and its conjugate base, or a weak base and its conjugate
acid. In either case, the property of a buffer solution is that its
pH changes very little when a small amount of acid or base is
added to it. Accordingly, buffer solutions are used to keep pH
at a nearly constant value in various chemical applications.
As discussed above, dispersing CNTs in an aqueous solu-
tion has generally required an additive in order to overcome
the hydrophobic nature of CNTs. Unfortunately, these addi-
tives wrap around the CNTs and prevent attachment of reac-
tants (e.g., catalysts in the case of CNT-based electrodes) to
the CNTs. The present invention overcomes these problems
by use of an aqueous buffer solution that includes water, a
buffer material, and possibly salt. The buffer material is
defined generally by a molecular structure having a cyclic
ring with nitrogen and oxygen heteroatomes at one end, a
charged group at the other end, and a hydrophobic alkyl chain
between and coupling the cyclic ring to the charged group.
One such suitable commercially-available buffer material is
3-(N-morpholino) propanesultonic acid (or "MOPS" as it is
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known and will be referred to hereinafter). The molecular
structure of the MOPS buffer is illustrated in FIG.1 where the
cyclic ring is contained within dashed-line circle 10, the alkyl
chain is contained within dashed-line oval 12, and the charged
group is contained within dashed-line circle 14. The alkyl 5
chain 12 separates the hydrophobic cyclic ring 10 from the
hydrophobic charged group 14. In general, a longer hydro-
phobic alkyl chain 12 improves CNT dispersion. For MOPS,
the length of its alkyl chain is approximately 0.45 nanom-
eters.	 10
The aqueous buffer solution in the present invention com-
prises at least 50 weight percent water. The remaining weight
percent of the aqueous buffer solution comprises a buffer
material satisfying the above-described criteria and, option- 15
ally, a small amount of salt. When using the MOPS buffer
material, good CNT dispersal was achieved when the weight
percent of the MOPS buffer material was approximately
between 1.05-50 weight percent.
The present invention's aqueous buffer solution can be 20
mixed in accordance with well known solution making prin-
ciples. That is, no special criteria need be adhered to when
creating the solution. Once created, CNTs are added to the
aqueous buffer solution. Based on dispersion analysis of a
number of examples, good dispersion of CNTs resulted when 25
the concentration of CNTs ranged up to approximately 1.0
milligrams per milliliter of the aqueous buffer solution. Initial
mixing of the CNTs in the solution can be accomplished by
stirring and/or sonication as would be understood in the art. In
all test examples of the present invention, good dispersion of 30
CNTs was visually evident after initial mixing with the clear
aqueous buffer solution. That is, prior to mixing, the CNTs
could be seen in aggregation in the clear solution whereas,
after mixing, the entire mixture became opaque. Any subse-
quent aggregation of the CNTs was quickly re-mixed with 35
just several minutes of sonication. Several examples of the
present invention are detailed below.
EXAMPLE I
40
The aqueous buffer solution in this example comprised 2.1
weight percent MOPS, 0.29 weight percent salt, and a
remaining weight percent of water. The pH of this solution
was 7.5. CNTs were mixed at a ratio of 0.5 milligrams/
milliliter of the aqueous buffer solution. 	 45
EXAMPLE 2
The aqueous buffer solution in this example comprised 2.1
weight percent MOPS and a remaining weight percent water. 50
No salt was added. The pH of this solution was 7.5. CNTs
were mixed in at a ratio of 1.0 milligrams/milliliter of the
aqueous buffer solution.
EXAMPLE 3	 55
The aqueous buffer solution in this example comprised 26
weight percent MOPS and a remaining weight percent of
water. No salt was added. The pH of this solution was 7.5.
CNTs were mixed in at a ratio 3.0 milligrams/milliliter of the 60
aqueous solution. Note that this higher ratio of CNTs did not
yield good dispersion results.
EXAMPLE 4
65
The aqueous buffer solution in this example comprised 50
weight percent MOPS and a remaining weight percent of
4
water. No salt was added. The pH of this solution was 7.5.
CNTs were mixed in at a ratio of 0.5 milligrams/milliliter of
the aqueous solution.
The advantages of the above-described CNT-dispersion
method are numerous. The safe-to-handle aqueous buffer
solution disclosed herein provides excellent CNT dispersion
without use of additives that tend to wrap themselves about
the CNTs. Thus, the present invention serves as a cornerstone
for the assembly of reactant materials on CNTs. For example,
the aqueous buffer solution with CNTs dispersed therein
could further have a variety of biomolecules mixed therewith.
In general, biomolecules carrying a positive charge on the
surface thereof are ideally suited to bond with the dispersed
CNTs. Thus, the present invention can serve as the building
block for a number of biological or biophysical applications
where CNTs serve as the vehicle for a particular biomolecule.
The present invention can also serve as the initial construc-
tion steps for fabrication of electrodes that use CNTs as their
support. This can be accomplished by mixing metal-core
ferritins with the above-described "aqueous buffer solution
with CNTs dispersed therein". As will be explained further
below, the ferritins are used to store nano-sized particles of
metal. The ferritins have a natural affinity for the CNTs so that
the stored nano-sized particles of metal can be distributed
about the dispersed CNTs. This affinity can be enhanced by
using cationized ferritins.
As is known in the art, ferritins are iron storage proteins
involved in a variety of human, animal, and bacteria mecha-
nisms. A ferritin molecule contains up to approximately 4500
Fe3+ atoms (e.g., Fe(OH)) within its hollow interior. The
ferritin molecule consists of a segmented protein shield with
an outer diameter of approximately 7.5 mm. The protein shell
consists of 24 protein subunits that form a spherical exterior
with channels through which molecules can enter and leave
the protein. When the protein shell is empty and contains no
iron, it is called apoferritin. Using a reconstitution process of
site-specific biomineralization within the protein shell, apo-
ferritins can be loaded with different core materials to include
good electrode materials such as cobalt, copper, gold, iron,
manganese, nickel, palladium, platinum, platinum-ruthe-
nium alloy, ruthenium, ruthenium-tungsten alloy, and silver.
Ferritin reconstitution processes are disclosed by Jae-Woo
Kim et al. in "Cobalt Oxide Hollow Nanoparticles Derived by
Bio-templating," Chemical Communication, The Royal Soci-
ety of Chemistry 2005, pp. 4101-4103, and by Jae-Woo Kim
et al. in "Electrochemically Controlled Reconstitution of
Immobilized Ferritins for Bioelectronic Applications," Jour-
nal of Electroanalytical Chemistry 601 (2007), pp. 8-16.
By way of example, naturally existing ferritins were recon-
stituted with nano-sized particles of platinum. Specifically,
horse spleen ferritins were reconstituted with platinum hav-
ing 200 atoms per ferritin using site-specific chemical reduc-
tion explained in the references cited herein. The resulting
platinum-core ferritins were mixed into a version of the
above-described solution (i.e., 2.1 weight percent MOPS and
remaining weight percent water) with dispersed CNTs. The
naturally existing ferritins have a negatively charged surface
in a pH environment of 7.5 because the isoelectric point of the
ferritin is around a pH of 4.5. As a result, a number of the
supplied platinum-core ferritins were electrostatically
repelled from the CNTs. Even so, this still yielded a distrib-
uted population of platinum catalyst on the CNTs as evi-
denced in the STEM image shown in FIG. 2 where the plati-
num-core ferritins appear as dark spots on the lighter-shade
CNTs. For the illustrated example, the CNTs were purified
FWCNTs mixed in the aqueous buffer solution at a ratio of
0.03 milligrams/milliliter. The ratio of FWCNTs to platinum-
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core ferritins was 1 to 1.47 in terms of weight. The total
platinum loading in the solution was 44.3 micrograms.
It was discovered that the population of the platinum cata-
lyst could be increased by using cationized ferritins in the
reconstitution process as opposed to naturally existing fer-
ritins. As is known in the art, a cationized ferritin has positive
charges on the protein surface through modification with
N,N-dimethyl-1,3-propanediamine (DMPA). Fabrication of
the platinum-core cationized ferritins followed the same pro-
cess as fabrication of the platinum-core ferritins. When plati-
num-core cationized ferritins were mixed in the above-de-
scribed solution with dispersed CNTs, greater numbers of the
platinum-core cationized ferritins easily attached themselves
to the negatively charged CNT surfaces via electrostatic
forces. As a result, an increased population of catalyst mate-
rial (i.e., in the form of platinum-core cationized ferritins)
could be found on the CNTs as evidenced in the STEM image
shown in FIG. 3 where the platinum-core cationized ferritins
appear as dark spots/regions on the lighter-shade CNTs. The
solution with the dispersed CNTs for this example again
comprised 2.1 weight percent MOPS and a remaining weight
percent water. For this example, the CNTs were purified
SWCNTs mixed in the aqueous buffer solution at a ratio of
0.083 milligrams/milliliter. The ratio of SWCNTs to cation-
ized platinum-core ferritins was 1 to 0.4 in terms of weight.
The total platinum loading in the solution was 33.3 micro-
grams.
The electrodes fabricated in the two examples just
described were then tested. The electrocatalytic behavior for
oxygen reduction was better for the electrode made with
platinum-core cationized ferritins. Specifically, the electrode
made with platinum-core cationized ferritins showed oxygen
reduction that commenced at a lower voltage potential while
producing about twice the current density when compared to
the electrode made with platinum-core ferritins. In addition to
these improvements, it was also discovered that subsequent
sonication of the electrodes made with the platinum-core
cationized ferritins (still in the aqueous buffer solution)
caused dissociation of the ferritins, protein shell. This
allowed the platinum particles to be redistributed and reorga-
nize into non-spherical groups thereby defining greater sur-
face areas of platinum catalyst. The result was further
improvements in electrode performance with respect to start-
ing potential of oxygen reduction and current density.
The advantages of the above described electrode fabrica-
tion method and resulting electrodes are numerous. CNTs are
readily dispersed in a safe-to-handle aqueous buffer solution
with the surfaces of the dispersed CNTs being available to
react with a selected reactant. The use of ferritin proteins as
the catalyst vehicle on a CNT support provides electrodes for
both biofuel cell and fuel cell applications. This process
involves safe-to-handle materials and is readily repeated
using conventional mixing techniques. The catalytic effects
of the resulting electrodes can be further enhanced by simple
sonication to redistribute and re-shape the metal particles on
the CNTs. Conversely, the use and retention of the ferritin
proteins on the electrode can improve proton transport
through the protein shield to thereby enhance the perfor-
mance of the metal-core as a catalyst.
Although the invention has been described relative to a
specific embodiment thereof, there are numerous variations
and modifications that will be readily apparent to those
skilled in the art in light of the above teachings. It is therefore
to be understood that, within the scope of the appended
claims, the invention may be practiced other than as specifi-
cally described.
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What is claimed as new and desired to be secured by
Letters Patent of the United States is:
1. A method of dispersing carbon nanotubes (CNTs) in a
solution, comprising the steps of:
5 creating an aqueous buffer solution consisting of at least 50
weight percent water and a remainder weight percent
that includes a buffer material having a molecular struc-
ture defined by a first end, a second end, and a middle
disposedbetween saidfirst end and said second end, said
10 first end defined by a cyclic ring with nitrogen and oxy-
gen heteroatoms, said middle defined by a hydrophobic
alkyl chain at least approximately 0.45 nanometers in
length, and said second end defined by a charged group;
mixing CNTs in said aqueous buffer solution in a ratio of
15 up to approximately 1.0 milligrams of CNTs per 1.0
milliliter of said aqueous buffer solution wherein a
resulting solution includes said CNTs dispersed therein;
and
mixing metal-core cationized ferritins into said resulting
20	 solution.
2. A method according to claim 1, wherein said CNTs are
selected from the group consisting of single-wall CNTs, few-
wall CNTs, multi-wall CNTs, and mixtures thereof.
3. A method according to claim 1, further comprising the
25 step of mixing biomolecules into said resulting solution, said
biomolecules having positively charged surfaces.
4. A method according to claim 1, wherein said buffer
material comprises 3-(N-morpholino)-propanesulfonic acid.
5. A method according to claim 4, wherein a metal used in
30 making said ferritins is selected from the group consisting of
cobalt, copper, gold, iron, manganese, nickel, palladium,
platinum, platinum-ruthenium alloy, ruthenium, ruthenium-
tungsten alloy, and silver.
6. A method according to claim 1, further comprising the
35 step of sonicating said resulting solution.
7. A method of dispersing carbon nanotubes (CNTs) in a
solution, comprising the steps of:
mixing approximately 1.05-50 weight percent 3-(N-mor-
pholino)-propanesulfonic acid with a remaining weight
40	 percent of water to form an aqueous buffer solution;
mixing CNTs in said aqueous buffer solution in a ratio of
up to approximately 1.0 milligrams of CNTs per 1.0
milliliter of said aqueous buffer solution wherein a
resulting solution includes said CNTs dispersed therein;
45	 and
mixing metal-core cationized ferritins into said resulting
solution.
8. A method according to claim 7, wherein said CNTs are
selected from the group consisting of single-wall CNTs, few-
50 wall CNTs, multi-wall CNTs, and mixtures thereof.
9. A method according to claim 7, further comprising the
step of mixing biomolecules into said resulting solution, said
biomolecules having positively charged surfaces.
10.A method according to claim 7, wherein a metal used in
55 making said ferritins is selected from the group consisting of
cobalt, copper, gold, iron, manganese, nickel, palladium,
platinum, platinum-ruthenium alloy, ruthenium, ruthenium-
tungsten alloy, and silver.
11. A method according to claim 7, further comprising the
60 step of sonicating said resulting solution.
12. A method of dispersing carbon nanotubes (CNTs) in a
solution, comprising the steps of:
creating an aqueous buffer solution consisting of at least 50
weight percent water and a remainder weight percent of
65 a buffer material having a molecular structure defined by
a first end, a second end, and a middle disposed between
said first end and said second end, said first end defined
US 7,998,368 B2
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by a cyclic ring with nitrogen and oxygen heteroatoms,
said middle defined by a hydrophobic alkyl chain that is
at least approximately 0.45 nanometers in length, and
said second end defined by a charged group;
mixing metal-core cationized ferritins into said solution . 5
and
mixing CNTs in said aqueous buffer solution in a ratio of
up to approximately 1.0 milligrams of CNTs per 1.0
milliliter of said aqueous buffer solution wherein a
resulting solution includes said CNTs dispersed therein. io
13. A method according to claim 12, wherein said buffer
material comprises 3-(N-morpholino)-propanesulfonic acid.
14. A method according to claim 12, wherein said CNTs
are selected from the group consisting of single-wall CNTs,
few-wall CNTs, multi-wall CNTs, and mixtures thereof.
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15.A method according to claim 12, further comprising the
step of mixing biomolecules into said resulting solution, said
biomolecules having positively charged surfaces.
16. A method according to claim 12, wherein said buffer
material comprises 3-(N-morpholino)-propanesulfonic acid,
and wherein said method further comprises the step of mixing
metal-core cationized ferritins into said resulting solution.
17. A method according to claim 16, wherein a metal used
in making said ferritins is selected from the group consisting
of cobalt, copper, gold, iron, manganese, nickel, palladium,
platinum, platinum-ruthenium alloy, ruthenium, ruthenium-
tungsten alloy, and silver.
18.A method according to claim 12, further comprising the
step of sonicating said resulting solution.
